首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Pathological overproduction: the bad side of adenosine
【2h】

Pathological overproduction: the bad side of adenosine

机译:病理性生产过剩:腺苷的不利方面

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adenosine is an endogenous ubiquitous purine nucleoside, which is increased by hypoxia, ischaemia and tissue damage and mediates a number of physiopathological effects by interacting with four GPCRs, identified as A1, A2A, A2B and A3. Physiological and acutely increased adenosine is mostly associated with beneficial effects that include vasodilatation and a decrease in inflammation. In contrast, chronic overproduction of adenosine occurs in important pathological states, where long‐lasting increases in the nucleoside levels are responsible for the bad side of adenosine associated with chronic inflammation, fibrosis and organ damage. In this review, we describe and critically discuss the pathological overproduction of adenosine and analyse when, where and how adenosine exerts its detrimental effects throughout the body.
机译:腺苷是一种内源性遍在嘌呤嘌呤核苷,由于缺氧,局部缺血和组织损伤而增加,并通过与四个GPCR相互作用来介导许多生理病理作用,分别被鉴定为A1,A2A,A2B和A3。生理上和急剧增加的腺苷主要与有益作用相关,包括血管舒张和炎症减轻。相反,腺苷的慢性过量生产发生在重要的病理状态,其中核苷水平的长期持续升高是腺苷与慢性炎症,纤维化和器官损伤相关的不良方面的原因。在这篇综述中,我们描述并批判性地讨论了腺苷的病理过度产生,并分析了腺苷何时,何地以及如何在整个人体中发挥其有害作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号